Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Imeson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 yearS A Burchill, I J Lewis, K R Abrams, et al.
Atherosclerosis|November 1, 1992
Hageman factor and risk of myocardial infarction in middle-aged menC C Kelleher, K A Mitropoulos, J Imeson, et al.
Medical and Pediatric Oncology|February 25, 1998
UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study GroupJ R Mann, F Raafat, K Robinson, et al.
Pediatric Blood & Cancer|February 18, 2004
Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) studyR G Grundy, C Hutton, H Middleton, et al.
Pediatric Surgery International|May 2, 2003
Sacrococcygeal teratomas: the UK Children's Cancer Study Group's experience. I. NeonatalS N Huddart, J R Mann, K Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicityJ R Mann, F Raafat, K Robinson, et al.
British Journal of Cancer|August 17, 2000
The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour studyC Mitchell, P M Jones, A Kelsey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group TrialH Thomas, A V Boddy, M W English, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 yearS A Burchill, I J Lewis, K R Abrams, et al.
Atherosclerosis|November 1, 1992
Hageman factor and risk of myocardial infarction in middle-aged menC C Kelleher, K A Mitropoulos, J Imeson, et al.
Medical and Pediatric Oncology|February 25, 1998
UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study GroupJ R Mann, F Raafat, K Robinson, et al.
Pediatric Blood & Cancer|February 18, 2004
Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) studyR G Grundy, C Hutton, H Middleton, et al.
Pediatric Surgery International|May 2, 2003
Sacrococcygeal teratomas: the UK Children's Cancer Study Group's experience. I. NeonatalS N Huddart, J R Mann, K Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicityJ R Mann, F Raafat, K Robinson, et al.
British Journal of Cancer|August 17, 2000
The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour studyC Mitchell, P M Jones, A Kelsey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group TrialH Thomas, A V Boddy, M W English, et al.
Pageof 2